Related Experiment Videos
Insights into cancer from transgenic mouse models
1Department of Molecular and Cellular Pathology, University of Dundee, Ninewells Hospital, Scotland, U.K. K.F.MACLEOD@dundee.ac.uk
The Journal of Pathology
|May 26, 1999
Summary
Genetically engineered mouse models (EMM) help link gene function to cancer processes like proliferation and metastasis. These models advance our understanding of tumor development and cancer therapy research.
Area of Science:
- Oncology
- Genetics
- Animal Models
Background:
- Engineered mouse models (EMM) overexpressing oncogenes or mutated tumor suppressor genes are crucial for cancer research.
- These models enable causal links between gene function and tumor processes like proliferation, apoptosis, angiogenesis, and metastasis.
Purpose of the Study:
- To investigate the role of genetic mutations in tumor development and progression using mouse models.
- To understand gene cooperativity in multi-stage tumorigenesis.
- To identify genetic modifiers influencing tumor phenotypes.
Main Methods:
- Generation of transgenic mice with specific oncogene activations or tumor suppressor gene mutations.
- Interbreeding of mouse strains to study genetic lesion cooperativity.
- Analysis of strain-dependent phenotypes to identify modifier loci.
- Development of conditional mouse mutants for tissue-specific gene effect studies.
Main Results:
- Established causal links between gene function and specific tumor processes.
- Demonstrated the multi-stage nature of tumorigenesis through genetic lesion cooperativity studies.
- Identified modifier loci influencing tumor development based on genetic background.
- Showcased the relevance of mouse models to human cancer mechanisms.
Conclusions:
- Engineered mouse models are invaluable tools for understanding cancer biology.
- Conditional mutagenesis enhances the utility of mouse models for tissue-specific cancer research.
- These models are critical for developing and testing novel cancer therapies.